Regulatory T cells clonally expand and contribute to stromal cell function in fibrotic response to synthetic implants
Authors:
- Joscelyn C. MejíasJMJoscelyn C. Mejías
- Kavita KrishnanKKKavita Krishnan
- A. Shri RamanujamARA. Shri Ramanujam
- Elise F. Gray-GaillardEGElise F. Gray-Gaillard
- Locke Davenport HuyerLHLocke Davenport Huyer
- David R. MaestasDMDavid R. Maestas
- Frank Haoning YuFYFrank Haoning Yu
- Alexandra N. RindoneARAlexandra N. Rindone
- Peter AbrahamPAPeter Abraham
- Maria BrowneMBMaria Browne
Preprint
Abstract
Fibrosis plays a key role in both chronic disease progression and failure of synthetic biomaterial implants. However, the contribution of adaptive immunity to fibrotic development remains incompletely understood, particularly for regulatory T cells (Tregs). Here, we used single-cell multiomic profiling, integrating transcriptomics with T cell receptor (TCR) sequencing, to map Treg heterogeneity and clonal dynamics in a synthetic material-induced model of fibrosis. We uncovered progressive Treg clonal expansion accompanied by TCR activation signatures and an increasingly immunosuppressive phenotype along a continuous transcriptional trajectory. These Tregs suppressed immune responses and influenced extracellular matrix and vascular gene expression. Cell-cell communication inference predicted Treg-driven activation of pro-fibrotic and vasculogenic transcriptional programs in fibroblasts and endothelial cells, including Sox-family transcription factors. Functional Treg depletion increased inflammation and significantly reduced neovascularization. Together, these findings identify Treg functions in the fibro-vascular niche through stromal cell modulation, highlighting immune-stromal interactions as an important axis in fibrosis.Keywords
Funding Information
- National Cancer Institute (CA006973)
- National Science Foundation (DGE1746891)
This publication has 125 references indexed in Scilit:
- Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologiesGeroScience, 2023
- Depletion of Foxp3+ regulatory T cells but not the absence of CD19+IL‐10+ regulatory B cells hinders tumor growth in a para‐orthotopic neuroblastoma mouse modelInternational Journal of Cancer, 2022
- Complex heatmap visualizationiMeta, 2022
- TGF‐β as a driver of fibrosis: physiological roles and therapeutic opportunitiesThe Journal of Pathology, 2021
- Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic SclerosisArthritis & Rheumatology, 2019
- TNF‐α‐induced NF‐κB activation promotes myofibroblast differentiation of LR‐MSCs and exacerbates bleomycin‐induced pulmonary fibrosisJournal of Cellular Physiology, 2017
- CD69: from activation marker to metabolic gatekeeperEuropean Journal of Immunology, 2017
- Inhibition of activator protein 1 signaling abrogates transforming growth factor β–mediated activation of fibroblasts and prevents experimental fibrosisArthritis & Rheumatism, 2011
- Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesisAngiogenesis, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001